N. Imai

A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan

K. Ohta, M. Adachi, Y. Tohda, 2016, International Archives of Allergy and Immunology.

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.

T. Kishimoto, K. Yoshizaki, N. Nishimoto, 2003, The Journal of rheumatology.

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma.

K. Ohta, T. Kamei, M. Adachi, 2017, Allergology international : official journal of the Japanese Society of Allergology.

Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.

H. Nakahama, N. Imai, S. Kubori, 1992, Nephron.

Acute glomerulonephritis in an 85-year-old woman

H. Nakahama, O. Uyama, M. Sugita, 1993 .

[A case of silicosis with MPO-ANCA-associated glomerulonephritis and alveolar hemorrhage].

N. Imai, S. Yamamoto, T. Yokokawa, 2001, Nihon Jinzo Gakkai shi.

Distinct responses of interleukin-6 and other laboratory parameters to treatment in a patient with Wegener's granulomatosis.

H. Nakahama, O. Uyama, M. Sugita, 1993, Internal medicine.

Distinct Responses of Interleukin-6 and Other Laboratory Parameters to Treatment in a Patient with Polyarteritis Nodosa—A Case Report

H. Nakahama, N. Imai, S. Kubori, 1992, Angiology.